Screener
ANI Pharmaceuticals ANIP Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $360.25M+65.4% | $311.21M+108% | $285.62M+97.1% | $262.65M+81.1% | $217.83M-9.3% | ||
| $274.47M+21.6% | $255.43M+15.9% | $281.08M+26.8% | $252.62M+28.6% | $225.65M+35.9% | ||
| $143.15M+3.5% | $143.47M+4.4% | $143.07M+4.6% | $146.48M-1.1% | $138.32M+10.3% | ||
| $825.43M+37.0% | $747.08M+39.3% | $753.12M+42.5% | $698.4M+34.0% | $602.63M+8.5% | ||
| $73.22M+23.6% | $67.12M+15.4% | $62.48M+9.9% | $63.56M+12.1% | $59.25M+14.7% | ||
| $62.48M+3.2% | $62.48M+3.0% | $62.48M+4.2% | $62.48M+3.4% | $60.53M+114% | ||
| $449.86M-13.5% | $467.16M-10.6% | $479.53M-11.5% | $499.82M-9.1% | $520.32M+219% | ||
| $1.49B+11.3% | $1.42B+10.0% | $1.44B+12.1% | $1.41B+9.4% | $1.34B+45.9% | ||
| $73.83M+35.3% | $69.69M+31.4% | $62.58M+37.1% | $69.8M+14.6% | $54.57M+12.1% | ||
| $21.33M+61.4% | $19.3M+72.4% | $17.27M+88.3% | $15.24M+113% | $13.22M+1,455% | ||
| $283.66M+19.8% | $239.51M+18.7% | $278.11M+43.0% | $270.56M+42.4% | $236.84M+69.2% | ||
| $280.16M-7.1% | $286M-6.3% | $291.84M-5.6% | $297.68M-4.9% | $301.48M+6.0% | ||
| $896.9M+1.8% | $859.67M+1.3% | $899.65M+5.1% | $902.34M+5.3% | $881.39M+100% | ||
| $3K+50.0% | $3K+50.0% | $3K+50.0% | $3K+50.0% | $2K0.0% | ||
| $31.1M+140% | $6.39M+108% | -$23.1M+77.0% | -$50.59M+43.5% | -$76.86M-18.2% | ||
| $597.21M+36.7% | $562.3M+34.3% | $540.72M+33.9% | $505.82M+24.6% | $436.76M-4.2% | ||
| $1.49B+11.3% | $1.42B+10.0% | $1.44B+12.1% | $1.41B+9.4% | $1.34B+45.9% |
FAQ
- What are ANI Pharmaceuticals's total assets?
- ANI Pharmaceuticals (ANIP) holds $1.5B in total assets, up 11.3% year over year.
- How much debt does ANI Pharmaceuticals have?
- ANI Pharmaceuticals carries $301.5M in total debt against $597.2M of shareholders' equity, a debt-to-equity ratio of 0.50.
- How much cash does ANI Pharmaceuticals have?
- ANI Pharmaceuticals holds $360.2M in cash and equivalents.
- Can ANI Pharmaceuticals cover its short-term obligations?
- Its current ratio is 2.91 — current assets exceed current liabilities.
- Where does ANI Pharmaceuticals's balance sheet data come from?
- Every line is extracted from ANI Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
